New briefing highlights actions to ensure access to best-practice heart failure care in Italy

News & Events

13 April 2023
AUTHOR: Ellen McIntosh

The latest policy briefing in our From guidelines to action series highlights the opportunities for heart failure advocates to improve care in Italy.

Based on extensive research and expert interviews, the briefing  recommends specific actions, including:

The current health landscape in Italy means that the quality of care for people living with heart failure varies greatly across regions. However, the National Plan for Chronic Conditions does prioritise heart failure, providing an opportunity for advocacy groups to call for the Plan’s implementation in their area to address existing inequalities in care.

This briefing is the third in our From guidelines to action series, which aims to equip national advocates with a targeted analysis of the opportunities available in their countries, along with specific actions they can take to change the narrative in their region. All of the actions are supported by successful examples from a number of health interventions and interviews with national heart failure experts. The Italian briefing follows reports on France and Spain, with a German report due to be published soon.

Download the report in English

Download the report in Italian


More from News & Events

Five lessons from the European Heart Failure Mission launch
Five lessons from the European Heart Failure Mission launch ...
15 November 2023
In October 2023, the HFPN launched the European Heart Failure Mission Statement at the European Parliament. Here's five things we learned....
Read article
HFPN identifies six priority areas for future EU research in
HFPN identifies six priority areas for future EU research in...
27 October 2023
The HFPN has outlined six area which EU funding programmes should direct investments in heart failure research....
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .